CMS looking into whether to pay for Provenge
Dendreon shares fell $5.64, or 17.5 percent, in after-hours trading last night
Dendreon shares fell $5.64, or 17.5 percent, in after-hours trading last night
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced its purchase of the Lexington Technology Park campus in Lexington, Massachusetts.
Original Source of Shire Purchases Strategic Site in Massachusetts
Pharmaceutical and healthcare market research company Manhattan Research releases Taking the Pulse® Nurses v10.0, the latest iteration of its study focused on how nurses use digital resources, handheld devices, and other technologies in the professional setting.
Original Source of Manhattan Research Releases Latest Study Focused on How Nurses Use the…
AstraZeneca
Two big drugs got generic competition in the U.S. this week. First, there’s AstraZeneca’s ( NYSE: AZN )
Obviously, the fate of GlaxoSmithKline’s ( NYSE: GSK )
When Celgene
Bayer withdrew its patent lawsuit against Teva Pharmaceutical Industries for allegedly infringing Bayer’s Yaz contraceptive with its Gianvi generic, according to court documents. Report
Original Source of Bayer backs off Teva’s premature Yaz copy
Abbott Laboratories doesn’t plan to hold onto Solvay’s flu vaccine business. The company started marketing the unit last week, sources tell the Wall Street Journal , by sending out materials to several large healthcare companies. The business could fetch some €500 million, or $619 million. Abbott bought Solvay’s drugs…
Did financial ties to drugmaker AstraZeneca ( NYSE: AZN ) prejudice researchers in the pivotal trial that showed its cholesterol fighter Crestor prevented heart disease? An article in the new Archives of Internal Medicine raises that question, pointing out that nine of the 14 researchers who ran the Jupiter…